İçeriğe geç
akaturk Akademik ölçüm

Akademisyen

YUSUF KARAKAŞ

PROFESÖR

İSTANBUL KENT ÜNİVERSİTESİ SAĞLIK HİZMETLERİ MESLEK YÜKSEKOKULU TIBBİ HİZMETLER VE TEKNİKLER BÖLÜMÜ

  • Ana Dal Sağlık Bilimleri Temel Alanı
  • Yan Dal Tıbbi Onkoloji (İç Hastalıkları)

Kayıtlı çıktılara kısa bakış — ayrıntılar aşağıda.

  • Makale 53
  • Proje 0
  • Kitap 6
  • Bildiri 50
  • Patent 0
  • Sanatsal 0
Scopus (SJR) Q1 11 Q2 17 Q3 15 Q4 5
WoS (JCR) Q1 5 Q2 13 Q3 10 Q4 19
TR Index 7 makale

Alan+yıl+tür normalize OpenAlex yüzdelik — Clarivate ESI / SciVal değildir.

Üst %1 makale 0
Üst %10 makale 5
Ort. yüzdelik 54.0%
Üst %1 payı 0.0%
Üst %10 payı 11.1%

Makaleler

YÖKSİS ve OpenAlex kaynak ayrımıyla makaleler; quartile ve TR Index ile daraltabilirsiniz.

Dizin filtreleri

Toplam 53 yayın

Makale listesi

  1. 2025 Ostracism in Adolescent Cancer Patients and Predictors (OSTRACA Study): A Pilot Study of the Palliative Care Working Committee of the Turkish Oncology Group (TOG) Muğla Sıtkı Koçman Üniversitesi Tıp Dergisi DOI 10.47572/muskutd.1503098 YÖKSİS TR Index OpenAlex 8.1%
  2. 2025 Real-world treatment efficacy of ribociclib or palbociclib plus fulvestrant in hormone receptor-positive/HER2-negative metastatic breast cancer: Turkish Oncology Group (TOG) Study Clinical Breast Cancer DOI 10.1016/j.clbc.2025.03.003 YÖKSİS SJR Q2 JCR Q3 OpenAlex 88.9%
  3. 2025 HER2-low expression in patients with hormone receptor positive and HER2 negative advanced breast cancer treated with ribociclib or palbociclib in combination with endocrine therapy Turkish Journal of Clinics and Laboratory DOI 10.18663/tjcl.1639022 YÖKSİS TR Index OpenAlex 69.4%
  4. 2024 Overall approach to building LCA and recent studies in Türkiye Advances in Building Energy Research DOI 10.1080/17512549.2024.2361343 YÖKSİS SJR Q2 JCR Q2 OpenAlex 3.6%
  5. 2024 Treatment outcomes and prognostic factors in patients with driver mutant non-small cell lung cancer and de novo brain metastases Journal of scientific reports-A (Online) DOI 10.1038/s41598-024-56046-w YÖKSİS TR Index OpenAlex üst %10 OpenAlex 95.1%
  6. 2024 Activity of CDK4/6 inhibitors and parameters affecting survival in elderly patients in age-subgroups: Turkish Oncology Group (TOG) retrospective study BMC Cancer DOI 10.1186/s12885-024-13357-5 YÖKSİS SJR Q2 JCR Q2 OpenAlex 85.4%
  7. 2023 PROPSEA, safety evaluation of palbociclib and ribociclib in older patients with breast cancer: A prospective real-world TOG study Journal of Geriatric Oncology DOI 10.1016/j.jgo.2023.101604 YÖKSİS SJR Q2 JCR Q2 OpenAlex 88.5%
  8. 2023 Treatment efficacy of ribociclib or palbociclib plus letrozole in hormone receptor-positive/HER2-negative metastatic breast cancer Future Medicine Ltd DOI 10.2217/fon-2022-1287 YÖKSİS SJR Q1 JCR Q2 OpenAlex üst %10 OpenAlex 95.3%
  9. 2022 The real-life efficacy and safety of osimertinib in pretreated advanced non-small cell lung cancer patients with T790M mutation: a Turkish Oncology Group Study Journal of Cancer Research and Clinical Oncology DOI 10.1007/s00432-021-03748-7 YÖKSİS SJR Q1 JCR Q2 OpenAlex 60.4%
  10. 2022 Investigation of the validity and reliability of the Turkish version of the Functional Assessment of Cancer Therapy-Cognitive Function in cancer patients PALLIATIVE & SUPPORTIVE CARE DOI 10.1017/S147895152100136X YÖKSİS SJR Q1 JCR Q3 OpenAlex 77.6%
  11. 2022 Real life experience of patients with locally advanced gastric and gastroesophageal junction adenocarcinoma treated with neoadjuvant chemotherapy: a Turkish oncology group study Journal of Chemotherapy DOI 10.1080/1120009X.2022.2073159 YÖKSİS SJR Q3 JCR Q4 OpenAlex 7.9%
  12. 2020 pPrognostic Significance of Serum Insulin-Like Growth Factor-1 in Hepatocellular Cancer Patients: A Validation Study/p Journal of Hepatocellular Carcinoma DOI 10.2147/JHC.S258930 YÖKSİS SJR Q2 JCR Q2 OpenAlex 62.9%
  13. 2020 Multimodality Treatment in Malignant Peripheral Nerve Sheath Tumors Journal of Oncological Science DOI 10.37047/jos.2019-73127 YÖKSİS TR Index SJR Q4 OpenAlex 42.4%
  14. 2020 Worse patient–physician relationship is associated with more fear of cancer recurrence (Deimos Study): A study of the Palliative Care Working Committee of the Turkish Oncology Group (TOG) European Journal of Cancer Care DOI 10.1111/ecc.13296 YÖKSİS SJR Q3 JCR Q1 OpenAlex 53.4%
  15. 2020 Prognostic value of the 2017 World Health Organization Classification System for gastric neuroendocrine tumors: A single-center experience The Turkish Journal of Gastroenterology DOI 10.5152/tjg.2020.18919 YÖKSİS SJR Q3 JCR Q4 OpenAlex 45.9%
  16. 2019 Hakkari İlinde Görülen Kanser Türlerinin ve Prevalanslarının Değerlendirilmesi Acibadem Universitesi Saglik Bilimleri Dergisi DOI 10.31067/0.2019.235 YÖKSİS TR Index OpenAlex 29.1%
  17. 2019 Is microsatellite instability a negative prognostic factor in early stage endometrial cancer patients? Journal of Clinical Oncology DOI 10.1200/JCO.2019.37.15_suppl.e17107 YÖKSİS SJR Q1 JCR Q1
  18. 2019 Analysis of Fusobacterium nucleatum and Streptococcus gallolyticus in saliva of colorectal cancer patients Biomarkers in Medicine DOI 10.2217/bmm-2019-0020 YÖKSİS SJR Q2 JCR Q3 OpenAlex üst %10 OpenAlex 91.1%
  19. 2019 The role of ABO blood groups in glial neoplasms BRITISH JOURNAL OF NEUROSURGERY DOI 10.1080/02688697.2018.1522415 YÖKSİS SJR Q2 JCR Q4 OpenAlex 59.9%
  20. 2018 The Effect of Total Size of Lesions in Multifocal/Multicentric Breast Cancer on Survival Clinical Breast Cancer DOI 10.1016/j.clbc.2017.11.002 YÖKSİS SJR Q2 JCR Q3 OpenAlex 41.8%

Akademisyenlere dön